Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05067114 · ClinicalTrials.gov registry record
Solutions for Atrial Fibrillation Edvocacy (SAFE)
A clinical trial of Cardiovascular Diseases and Atrial Fibrillation, sponsored by American Pharmacists Association Foundation.
- Completed
- Registry status
- 650
- Enrollment target
- 1
- Study location
NCT05067114 is a study of Cardiovascular Diseases and Atrial Fibrillation that has completed, run by American Pharmacists Association Foundation. The registered enrollment target is 650 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05067114, a study of Cardiovascular Diseases and Atrial Fibrillation, has completed, sponsored by American Pharmacists Association Foundation.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this demonstration project is to create an additional access point in the community at local pharmacies for atrial fibrillation screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate.
Conditions Studied
Interventions
- DEVICE Screening, detection and referral for atrial fibrillation
Study Locations (1)
District of Columbia
- Central Study Sponsor Facility - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2021-09-03 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05067114
The ClinicalTrials.gov registry entry for NCT05067114 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The listed sponsor is American Pharmacists Association Foundation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Screening, detection and referral for atrial fibrillation is the first listed.
NCT05067114 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05067114 about?
NCT05067114 is a clinical study titled "Solutions for Atrial Fibrillation Edvocacy (SAFE)". The aim of this demonstration project is to create an additional access point in the community at local pharmacies for atrial fibrillation screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate.
What is the current status of trial NCT05067114?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2021-09-03. Estimated completion is 2022-06-30.
What conditions does trial NCT05067114 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Atrial Fibrillation, Cardiac Arrhythmia.
What interventions are being tested in trial NCT05067114?
The interventions under investigation include: Screening, detection and referral for atrial fibrillation (DEVICE).
Who is sponsoring clinical trial NCT05067114?
This trial is sponsored by American Pharmacists Association Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05067114 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Cardiovascular Diseases
All registered trials for this condition
Atrial Fibrillation
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.